Study of Silodosin to Facilitate Passage of Urinary Stones

Clinical trial NCT01144949 · COMPLETED

Trial details

NCT number: NCT01144949
Sponsor: Watson Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ureteral Calculi Kidney Stones Urolithiasis

Start date: 2010-06-01
Primary completion: 2012-07-01
Enrollment: 239

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.